Physician profile
Arthur Segall
NPI 1033108535
$5,801.63
in general payments reported to CMS, 2019-2025
30 companies · $930 in 2025
The $930 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,333 · 2020: $72.82 · 2021: $1,672 · 2022: $329 · 2023: $644 · 2024: $820 · 2025: $930.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,394.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,422.15 | 2019-2025 | Salvation, Prostep Mica, Prophecy |
| Wright Medical Technology, INC. | $1,192.66 | 2019 | |
| Smith+Nephew, INC. | $396.06 | 2021-2025 | Stravix Pl, Grafix Pl, Oasis |
| Biotissue Holdings INC. | $345.14 | 2021-2024 | |
| Depuy Synthes Sales INC. | $232.29 | 2019-2025 | Na, Monovisc |
| Access Pro Medical, LLC | $143.77 | 2025 | Matriderm |
| Ibsa Pharma INC. | $125.00 | 2024 | Licart |
| Organogenesis INC. | $109.17 | 2021-2025 | Puraply Wound Matrix |
| Grt US Holding, INC. | $89.83 | 2022 | |
| Aroa Biosurgery Incorporated | $89.24 | 2022-2024 | |
| Djo, LLC | $88.70 | 2021-2025 | Cmf |
| Polynovo North America LLC | $74.62 | 2025 | Novosorb Btm |
| Integra Lifesciences Corporation | $63.50 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $62.41 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Treace Medical Concepts, INC. | $58.04 | 2023-2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $30.65 | 2025 | Biobrace 23mm |
| Horizon Therapeutics Plc | $28.92 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $26.41 | 2025 | Exparel |
| Innovation Technologies INC | $26.19 | 2023 | Irrisept |
| Metric Medical Devices, INC. | $24.95 | 2023 | Super Staple, Super Scaffold |
| Paratek Pharmaceuticals, INC. | $22.83 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $20.63 | 2022 | |
| Bsn Medical INC | $19.59 | 2025 | |
| Kci USA, INC. | $18.26 | 2021 | |
| Bioventus LLC | $17.90 | 2022 | |
| Medtronic, INC. | $17.31 | 2023 | Intellis Adaptivestim |
| Amgen INC. | $16.70 | 2025 | Krystexxa |
| Ermi LLC | $14.28 | 2020 | |
| Acell, INC. | $13.35 | 2019 | |
| Zimmer Biomet Holdings, INC. | $11.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Segall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.